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Biosensors represent an interesting alternative for an efficient, fast, low-cost and user-
friendly clinical analysis in general and cancer diagnostic particularly. Between different 
biosensing alternatives the nanotechnology oriented biosensors or nanobiosensors 
represent a very attractive tool for clinical applications. The need for nucleic acid and 
protein based diagnostic tests has increased enormously in the last few years and the 
design of novel nanostructures with special optical and electrochemical properties is 
bringing significant advantages in several fields being diagnostic one of the most 
important.  
 
Electrochemical biosensors based on the use of nanoparticles (NPs) as electroactive 
labels may offer several advantages in terms of cost-efficiency in comparison to traditional 
methods of bioanalysis such as ELISA or PCR. Gold nanoparticles (AuNPs) stand out 
from the variety of nanoparticles used as labels in biosensing due to their simple 
synthesis, narrow size distribution, optical and electrochemical properties and easy 
bioconjugation alternatives. The advantageous properties of AuNP-based immuno and 
DNA electrochemical assays have given rise to an increased number of publications and 
other reports in the last years.  
 
The aim of this presentation is to show the different strategies developed in our group for 
the direct (redox properties) [1] and indirect (electrocatalytic properties) [2-4] 
electrochemical detection of AuNPs tags in immunosensing assays. Different platforms 
(i.e. magneto - screen-printed electrodes, nanoporous surfaces etc.) that improve the 
performance of the performed assays have been used so as to improve the biosensing 
performances.  
 
The developed immunosensors have been applied for the detection of model protein 
biomarkers in real clinical samples. The obtained results show that the developed 
technologies can be valid alternatives to the traditional methods. These works and their 
final validation in real samples analysis are still in progress at our laboratories and will be 
object of future presentations. 
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